Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.

Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.

Item
http://www.wikidata.org/entity/Q30981466
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyIdentification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells.Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging.Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Stainless steel surface functionalization for immobilization of antibody fragments for cardiovascular applications.Molecular cloning and characterization of a novel anti-TLR9 intrabody.Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.Cytotoxic Effect of Immunotoxin Containing The Truncated Form of Pseudomonas Exotoxin A and Anti-VEGFR2 on HUVEC and MCF-7 Cell Lines.ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling.Regulation of endothelial progenitor cell differentiation and function by dimethylarginine dimethylaminohydrolase 2 in an asymmetric dimethylarginine-independent manner.Activity of daily living is associated with circulating CD34+/KDR+ cells and granulocyte colony-stimulating factor levels in patients after myocardial infarction.
P2860

Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.

Item
http://www.wikidata.org/entity/Q30981466
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@ast
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@en
type
label
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@ast
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@en
prefLabel
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@ast
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Anti-VEGFR-2 scFvs for cell is ...... d CD34+ cells from cord blood.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921